MEDISCA Inc. FDA Inspection Record

FEI 1000120311 · Inspections, Form 483s, warning letters and import refusals

MEDISCA Inc. is an FDA-registered facility (FEI 1000120311) located in Plattsburgh, NY, US. Registered operations: RELABEL; REPACK. RegDataLab tracks 13 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Nov 20, 2025: Voluntary Action Indicated (VAI)
Inspections on record
13 (6 OAI, 6 VAI, 1 NAI)
Last OAI inspection
Apr 16, 2019
Warning letters
1 listed by FDA for this FEI, latest Nov 25, 2015
Recalls as the recalling firm
8, latest Jun 26, 2024
Import refusals
10 or more

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 13 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Nov 20, 2025Voluntary Action Indicated (VAI)No citations listed
Jul 16, 2024No Action Indicated (NAI)No citations listed
Oct 6, 2020Voluntary Action Indicated (VAI)No citations listed
Apr 16, 2019Official Action Indicated (OAI)No citations listed
Dec 8, 2017Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Apr 7, 2016Voluntary Action Indicated (VAI)No citations listed
Feb 27, 2014Official Action Indicated (OAI)No citations listed
Oct 24, 2012Voluntary Action Indicated (VAI)No citations listed
May 30, 2012Voluntary Action Indicated (VAI)No citations listed
Sep 23, 2010Official Action Indicated (OAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jun 26, 2024Class IID-0570-2024Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder…
CGMP Deviations and Presence of Particulate Matter: Glass
Nov 25, 2019Class IID-0622-2020Estriol, USP (Micronized) 1 g, 5 g, 25 g, 100 g, 2000 g, 1 kg, containers, Packed by…
Failed Impurities/Degradation Specifications
Sep 14, 2017Class IID-1174-2017Aminocaproic Acid, USP (6-Aminohexanoic Acid) active pharmaceutical ingredient, packaged…
CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.
Apr 3, 2017Class IID-0663-2017ESTRIOL, USP (Micronized) Bulk, in a) 5 grams (NDC 38779-0732-03), b) 25 grams (NDC… and 3 more products
cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
Feb 14, 2014Class ID-0674-2016CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or…
Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was…
Jul 29, 2011Class IIIF-0752-2012BETA CAROTENE, USP, in 5 grams (NDC 38779-0414-3), 25 grams (NDC 38779-0414-4), and 100…
The test results confirmed that the subject lots were no longer within USP specifications and the materials have significantly degraded…
Sep 11, 2007Class IIID-002-2008TESTOSTERONE CYPIONATE, USP, CIII, packed in 5 grams, 25 grams, 100 grams, 500 grams, 1…
Failed USP limit for Free Cyclopentanepropionic Acid.
Oct 1, 2002Class IIV-049-3Phenylbutazone, USP, NDC 38779-0497-7 sold in: (1) 25 kg fiber drums, (2) 5 kg plastic…
Expiration dates extended and lot numbers changed.

FDA record score

24 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

20 records behind this number
RecordDatePoints x age weightAdds
Inspection classified OAIApr 16, 201930 x 0.257.5
Inspection classified VAINov 20, 20256 x 16
64 import refusals in 2016Dec 31, 201610 x 0.252.5
Class II recall D-0570-2024, this FEI as the recalling firmJun 26, 20244 x 0.62.4
Inspection classified VAIOct 6, 20206 x 0.251.5
Inspection classified VAIDec 8, 20176 x 0.251.5
Class II recall D-0622-2020, this FEI as the recalling firmNov 25, 20194 x 0.251
Class II recall D-1174-2017, this FEI as the recalling firmSep 14, 20174 x 0.251
Class II recall D-0663-2017, this FEI as the recalling firmApr 3, 20174 x 0.251
Inspection classified VAIApr 7, 201610 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsNov 25, 201510 years or older, so it adds no points0
Inspection classified OAIFeb 27, 201410 years or older, so it adds no points0
Class I recall D-0674-2016, this FEI as the recalling firmFeb 14, 201410 years or older, so it adds no points0
Inspection classified VAIOct 24, 201210 years or older, so it adds no points0
Inspection classified VAIMay 30, 201210 years or older, so it adds no points0
Inspection classified OAISep 23, 201010 years or older, so it adds no points0
Inspection classified OAIOct 20, 200910 years or older, so it adds no points0
Inspection classified OAIMar 12, 200910 years or older, so it adds no points0
Inspection classified OAIDec 18, 200810 years or older, so it adds no points0
Class II recall V-049-3, this FEI as the recalling firmOct 1, 200210 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing MEDISCA Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check MEDISCA Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Medisca, Inc.
Location
Plattsburgh, NY (US)
Registration Expires
Dec 31, 2027
Operations
RELABEL; REPACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.